Class 4 caution in use-Caramet 25/100mg CR Tablet

Teva UK Limited, the Marketing Authorisation Holder (MAH) has informed the MHRA of a labelling error for the batch listed in this notification

MHRA drug alert date: 4th December 2023

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-teva-uk-ltd-dot-caramet-25-slash-100mg-cr-tablets-el-23-a-slash-40?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=fb44128a-df16-4382-837c-9ec3a1412da8&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information queries, please contact Teva UK Limited Medical Information via phone on 0207 540 7117 or via email medinfo@tevauk.com.

For stock control queries, please contact Teva UK Limited Customer Solutions via phone on 0800 590502 or via email customer.services@tevauk.com.